Interna

[Comment] Advancing tau-PET imaging in Alzheimer's disease

VIP article

The development of PET radioligands for the quantification of amyloid-β (Aβ) plaques over 20 years ago1 contributed substantially to Alzheimer's disease research, drug development, and clinical care. 10 years later, the development of radioligands for tau pathology,2 the second proteinopathy in Alzheimer's disease, has

ME

MedScopeGlobal Editorial

May 29, 2026

InternaVIP

Evidence-based clinical briefing

[Comment] Advancing tau-PET imaging

MedScope VIP

This article is reserved for VIP subscribers. Upgrade for full access, an ad-free reading experience, and priority clinical alerts.

View membership options

Doporučený obsah